SynthesisCurrent medicinal chemistry2026
The Anti-Aging Benefits of Phytoestrogens: Insights and Evidence.
Synthesis in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPhytoestrogens are polyphenolic bioactive compounds found in various plants and plant-based foods. The purpose of this study was to conduct a comprehensive analysis of the diversity and pharmacological potential of phytoestrogens in relation to age-related disorders, as well as to assess their potential toxicity.
methodsA systematic review of studies published over the last two decades was conducted, utilizing databases such as PubMed, Web of Science, and Scopus. The selection criteria focused on studies that explored the therapeutic effects of phytoestrogens.
resultsModern research has highlighted the significant therapeutic potential of phytoestrogens, particularly in sources like soy (Glycine max L.), red clover (Trifolium pratense L.), red grapes (Vitis vinifera L.), hops (Humulus lupulus L.), flaxseed (Linum usitatissimum L.), and black cohosh (Actaea racemosa L.). Soy isoflavones - genistein, equol, and daidzein - have been extensively studied through experimental and clinical trials, demonstrating their efficacy in managing aging-related health disorders. Similarly, resveratrol, a stilbene abundant in grapes and red wine, has well-documented phytoestrogenic properties. DISCUSSION: The wide-ranging health benefits of phytoestrogens include alleviation of menopausal symptoms and reduction in the risks of metabolic disorders, osteoporosis, hormone-dependent cancers, cardiovascular and brain diseases, as well as skin aging. While phytoestrogens can be advantageous in estrogen-deficient states, they may pose risks when excess estrogen is unnecessary. Thus, their effects are influenced by individual physiological conditions, suggesting that targeted intake through supplements or medications, coupled with reduced dietary exposure, could optimize benefits.
conclusionThis review systematically examines the chemical diversity, pharmacological effects, and therapeutic properties of phytoestrogens and their herbal sources, based on studies published over the last two decades, using data from PubMed, Web of Science, and Scopus.
Indexed as
Identifiers
41735208What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.